<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220904055869N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-06</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Effect of forehead cooling on cognitive functions.</public_title>
      <acronym>CTSD</acronym>
      <scientific_title>DEVELOPMENT OF A CORTICAL-THERMAL STIMULATION DEVICE (CTSD) TO REGULATE FRONTOPOLAR TEMPERATURE AND THE EXAMINATION OF ITS EFFECTS ON COGNITIVE FUNCTIONS; A PSYCHOMETRIC VALIDATION APPROACH</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-04-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65906</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Other, Randomization description: This study is a randomized clinical trial (phase 2-3 study) in which subjects were assigned to sham (control group) or true (intervention group) CTSD intervention through simple randomization in 1:1 ratio. We wrote the numbers 1-40 on papers of the same size and put them in a closed paper envelope. Then, after the participant agreed to participate in the study, we randomly picked a number from the envelope. If the number we picked was an even number, the participant was placed in the intervention group, and if there was an odd number, he/she was placed in the control group, Blinding description: How to conduct the study (use of Cortical Thermal Stimulating Device) and how the device works were explained to the participants and the informed consent form was completed, but during the study, the intervention group received the device ON and the control group as a sham (that is, the device turns off automatically after thirty seconds).</study_design>
      <phase>2-3</phase>
      <hc_freetext>The regulation of frontopolar temperature to enhancement of cognitive functions in healthy adults..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This study was conducted in 6 half-hour sessions, with a 24-hour interval between each session, and in each session the Cortical Thermal Stimulation Device was used for the participants. the Cortical Thermal Stimulation Device (made in the Department of Neurosciences of Shiraz University of Medical Sciences) has a headband part that is tied on the forehead of people and when the device is on, the temperature of the headband is in a certain temperature is kept constant, and in this study, for the intervention group, the device is placed on the forehead of the people for 30 minutes and keeps the temperature of this area constant at 34 degrees Celsius. It should be noted that this temperature was chosen based on previous studies. Intervention 2: Control group: according to the intervention group, the headband of the Cortical Thermal Stimulation Device is placed on the forehead of the people and the device is turned on, but in this group, thirty seconds after the start, the device is automatically turned off.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The results of part of the data will be reported in the form of an article, and the rest of the data (quantitative EEG and fNIRS) will also be used as a database for signal processing after deidentifying people.

When:
The access period starts 6 months after the results are published.

To whom:
Researchers working in academic and scientific institutions

Conditions:
Using information as a database and signal processing

Where to obtain:
Register action through roohollaz1991@yahoo.com

How to obtain:
Registering the request through the said email, identifying the person's identity and resume (to check employment in academic and scientific institutions), sending information

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Nami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 402, Floor 3, Mahyar apartment, 4 Alley, Esteghlal Blvd, Shiraz, IRAN</address>
        <city>shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7173686674</zip>
        <telephone>+98 71 3230 0535</telephone>
        <email>roohollaz1991@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Nami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 402, Floor 3, Mahyar apartment, 4 Alley, Esteghlal Blvd, Shiraz, IRAN</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7173686674</zip>
        <telephone>+98 71 3230 0535</telephone>
        <email>roohollaz1991@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>No significant of cognitive impairment and head trauma
stable medical condition
The age range 18-40 years old
Residence in Shiraz
Being literate enough to cooperate with the examiners
The point of Raven's Progressive Matrices would be above 90</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Observation of any neuropsychological disorder or medical illness
Drug abuse or alcoholism</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This study was conducted in 6 half-hour sessions, with a 24-hour interval between each session, and in each session the Cortical Thermal Stimulation Device was used for the participants. the Cortical Thermal Stimulation Device (made in the Department of Neurosciences of Shiraz University of Medical Sciences) has a headband part that is tied on the forehead of people and when the device is on, the temperature of the headband is in a certain temperature is kept constant, and in this study, for the intervention group, the device is placed on the forehead of the people for 30 minutes and keeps the temperature of this area constant at 34 degrees Celsius. It should be noted that this temperature was chosen based on previous studies.</i_keyword>
      <i_keyword>Control group: according to the intervention group, the headband of the Cortical Thermal Stimulation Device is placed on the forehead of the people and the device is turned on, but in this group, thirty seconds after the start, the device is automatically turned off.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The score of healthy adults in CANTAB battery. Timepoint: First to sixth sessions for half an hour simultaneously with temperature stimulation. Method of measurement: Cambridge Neuropsychological Test Automated Battery (CANTAB).</prim_outcome>
      <prim_outcome>The examination of oxygenated blood in the frontopolar area. Timepoint: Before and after the sessions 2-5 for three minutes. Method of measurement: functional Near InfraRed Spectroscopic (fNIRS).</prim_outcome>
      <prim_outcome>Brain map scores. Timepoint: Before and after the first and sixth session for 6 minutes. Method of measurement: quantitative Electroencephalogram.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-11</approval_date>
        <contact_name>Research Ethics Committees of Shiraz  University of Medical Sciences</contact_name>
        <contact_address>No. 4, Esteghlal Blvd, Shiraz Town Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
